FDA Warns About Seizure Medication
The FDA has issued a warning to consumers concerning the anti-seizure drug ezogabine (Potiga). As reported by MedPage Today, the drug can cause “blue skin discoloration” and “pigment changes in retinas”.
A loss of vision and eye disease are possible if the drug is continued to be used after initial symptoms arise, but doctors urge patients not to stop using the drug without consulting a physician. A sudden stop in the use of seizure medication can potentially cause “withdrawal seizures”, which can be fatal.
Instead, doctors urge patients who are being treated with ezogabine to undergo periodic eye exams and be on the lookout for any developing symptoms.